The Biggest ADA 2026 Obesity Drug Breakthroughs ADA 2026 delivered a massive wave of obesity and diabetes data, and in this episode of On The Pen, Dave Knapp (@manonthemounjaro) sits down with Jen (@JcanNuSH) to break down the molecules, clinical trials, weight loss results, and safety signals that could define the next generation of obesity and diabetes medicine
Nucleic Acids Res 46 , 1139611404 (2018)
A review of GHK-Cu s wound healing and skin regeneration research by Pickart and Margolina (2018), highlighted the importance of sustained application for achieving the full range of GHK-Cu s documented biological effects
However, too much usage can be harmful
doi: Garabadu D, Verma J (2019) Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (142)-induced cognitive deficit rats